These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4608944)

  • 61. Serum immunosuppressive activity of azathioprine in normal subjects and patients with liver diseases.
    Bach JF; Dardenne M
    Proc R Soc Med; 1972 Mar; 65(3):260-3. PubMed ID: 4563301
    [No Abstract]   [Full Text] [Related]  

  • 62. The alcoholic metabolites of pentobarbital and amobarbital in man.
    Maynert EW
    J Pharmacol Exp Ther; 1965 Oct; 150(1):118-21. PubMed ID: 5855308
    [No Abstract]   [Full Text] [Related]  

  • 63. Overview of drug-protein binding.
    Gillette JR
    Ann N Y Acad Sci; 1973 Nov; 226():6-17. PubMed ID: 4588445
    [No Abstract]   [Full Text] [Related]  

  • 64. An assessment of short-cut procedures for studying drug metabolism in vivo using amobarbital as a model drug.
    Tang BK; Kalow W; Endrenyi L; Chan FY
    Eur J Clin Pharmacol; 1982; 22(3):229-33. PubMed ID: 7106156
    [No Abstract]   [Full Text] [Related]  

  • 65. Pharmacokinetics of glymidine (glycodiazine) and tolbutamide in acute and chronic liver diseases.
    Held H; Eisert R; von Oldershausen HF
    Arzneimittelforschung; 1973 Dec; 23(12):1801-7. PubMed ID: 4801689
    [No Abstract]   [Full Text] [Related]  

  • 66. Elementary pharmacokinetics in clinical practice. 5: The effect of pathological condition on pharmacokinetics.
    Paxton JW
    N Z Med J; 1982 Feb; 95(702):116-8. PubMed ID: 6952117
    [No Abstract]   [Full Text] [Related]  

  • 67. Hemodynamic drug interactions.
    Nies AS; Shand DG; Branch RA
    Cardiovasc Clin; 1974; 6(2):43-53. PubMed ID: 4613462
    [No Abstract]   [Full Text] [Related]  

  • 68. Persistence of phenylbutazone in horses producing acid urines.
    Moss MS; Haywood PE
    Vet Rec; 1973 Aug; 93(5):124-5. PubMed ID: 4763773
    [No Abstract]   [Full Text] [Related]  

  • 69. [Metabolism in vitro and metabolic clearance in vivo of tolbutamide in rats with experimental cholestasis].
    Gallenkamp H; Wilhelm T; Zilly W; Richter E
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():297-300. PubMed ID: 1029191
    [No Abstract]   [Full Text] [Related]  

  • 70. Determination of apparent kinetic constants of the microsomal hydroxylation of amobarbital, hexobarbital, and pentobarbital.
    Sitar DS; Mannering GJ
    Drug Metab Dispos; 1973; 1(5):663-8. PubMed ID: 4149704
    [No Abstract]   [Full Text] [Related]  

  • 71. Editorial: The significance and determinants of drug metabolism in man.
    Stevenson IH
    Digestion; 1973; 8(1):80-6. PubMed ID: 4776491
    [No Abstract]   [Full Text] [Related]  

  • 72. [Enzyme induction therapy of liver diseases].
    Hirayama C
    Nihon Rinsho; 1971 Oct; 29(10):2264-75. PubMed ID: 4945895
    [No Abstract]   [Full Text] [Related]  

  • 73. Influence of hepatic insufficiency in pharmacokinetics of drugs: example for an anthranilic diuretic.
    Dreux C; Passa P; Halter D
    Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):289-96. PubMed ID: 552592
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Steady-state intravenous pharmacokinetics of pirenzepine in patients with hepatic insufficiency and combined renal- and hepatic insufficiency.
    Krakamp B; Tanswell P; Leidig P; Vogel H; Schmitz R; Bozler G
    Eur J Clin Pharmacol; 1989; 36(1):71-3. PubMed ID: 2917592
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clearance and biologic half-life as indices of intrinsic hepatic metabolism.
    Perrier D; Gibaldi M
    J Pharmacol Exp Ther; 1974 Oct; 191(1):17-24. PubMed ID: 4423599
    [No Abstract]   [Full Text] [Related]  

  • 76. Altered drug metabolism in hepatosplenic schistosomiasis.
    Brant PC; Prata A
    Rev Inst Med Trop Sao Paulo; 1979; 21(5):254-9. PubMed ID: 549210
    [No Abstract]   [Full Text] [Related]  

  • 77. [Drug dosing in chronic hepatic disease (author's transl)].
    Gugler R; Eichelbaum M
    Leber Magen Darm; 1981 Apr; 11(2):81-7. PubMed ID: 7015045
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of liver function on the metabolism of prednisone and prednisolone in humans.
    Renner E; Horber FF; Jost G; Frey BM; Frey FJ
    Gastroenterology; 1986 Apr; 90(4):819-28. PubMed ID: 3512355
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Output of 14CO2 in breath after oral administration of (14C-methyl) aminopyrine in hepatitis, cirrhosis and hepatic bilharziasis: its relationship to aminopyrine pharmacokinetics.
    Noordhoek J; Dees J; Savenije-Chapel EM; Wilson JH
    Eur J Clin Pharmacol; 1978 May; 13(3):223-9. PubMed ID: 668778
    [No Abstract]   [Full Text] [Related]  

  • 80. [Aspects of cortisol metabolism in liver diseases].
    Della Casa L; Boni M
    Endocrinol Sci Cost; 1967 Nov; 29(5):344-53. PubMed ID: 5616116
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.